{"disease":{"id":"hiv-1-virologic-response","name":"hiv 1 virologic response"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT03500172","title":"HIV Treatment Retention Interventions for Women Living With HIV (Siyaphambili Study)","phase":"NA","overall_status":"COMPLETED","enrollment_count":1391,"lead_sponsor_name":"Johns Hopkins Bloomberg School of Public Health","has_results":true},{"nct_id":"NCT03251690","title":"Switching TDF/FTC/EFV to TDF/FTC/RPV VS Continuing TDF/FTC/EFV in HIV Patients With Complete Virological Suppression","phase":"NA","overall_status":"COMPLETED","enrollment_count":246,"lead_sponsor_name":"Mahidol University","has_results":false}],"total":2},"guidelines":[],"source":"Drug Landscape verified database"}